Covered recipient · General Payments record
VIRGINIA WRIGHT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$2,542.13
- Reported across 150 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $327.84 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $90.69 | 5 |
| DEXCOM, INC. | $52.57 | 2 |
| Lilly USA, LLC | $35.29 | 2 |
| Amgen Inc. | $34.70 | 2 |
| Medtronic, Inc. | $28.30 | 2 |
| Novo Nordisk AS | $23.87 | 1 |
| SANOFI-AVENTIS U.S. LLC | $23.78 | 1 |
| Kyowa Kirin, Inc. | $23.21 | 1 |
| Tandem Diabetes Care, Inc. | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.70 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300577 | CMS |
| Abbott Laboratories | $17.17 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300579 | CMS |
| Abbott Laboratories | $17.65 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300581 | CMS |
| Abbott Laboratories | $21.61 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300583 | CMS |
| Abbott Laboratories | $13.56 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125300585 | CMS |
| Amgen Inc. | $20.53 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116215363 | CMS |
| Amgen Inc. | $14.17 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116215367 | CMS |
| Dexcom, Inc. | $30.36 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153343221 | CMS |
| Dexcom, Inc. | $22.21 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153343223 | CMS |
| Kyowa Kirin, Inc. | $23.21 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127045293 | CMS |
| Lilly USA, LLC | $19.56 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135509326 | CMS |
| Lilly USA, LLC | $15.73 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135466586 | CMS |
| Medtronic, Inc. | $14.46 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119512985 | CMS |
| Medtronic, Inc. | $13.84 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119512987 | CMS |
| Novo Nordisk Inc | $23.87 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096655222 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.78 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139875500 | CMS |
| Tandem Diabetes Care, Inc. | $15.43 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138740845 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.